Enhancing Future Healthcare: The Importance of Oncofertility Education in German Medical Training Based on a Nationwide Survey of 346 Medical Students - Top-Institutions - MDSpire

Enhancing Future Healthcare: The Importance of Oncofertility Education in German Medical Training Based on a Nationwide Survey of 346 Medical Students

  • By

  • Judith Altmann

  • Desislava Dimitrova

  • Elena Stark

  • Nadine Einsiedel

  • Lea Heistermann

  • Jalid Sehouli

  • April 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Reproductive Endocrinology
    • Oncofertility

  • #2

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Reproductive Medicine
    • Oncology
    • Medical Education

  • #3

    Charité – Universitätsmedizin Berlin
    Charité – Universitätsmedizin Berlin

    Berlin, Berlin

    Key Differentiators

    • Gynecology
    • Reproductive Medicine
    • Medical Education

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Reproductive Endocrinology
    • Oncology
    • Medical Education

  • #5

    Dana-Farber Cancer Institute / Harvard Medical School
    Dana-Farber Cancer Institute / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Oncology
    • Reproductive Medicine
    • Medical Education

Original Source(s)

Enhancing Future Healthcare: The Importance of Oncofertility Education in German Medical Training Based on a Nationwide Survey of 346 Medical Students

  • by Judith Altmann, Desislava Dimitrova, Elena Stark, Nadine Einsiedel, Lea Heistermann, Jalid Sehouli

  • April 29, 2026

Related Content

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

FOXA2 in cancer: from fundamental biology to clinical translation